person

Secondo L.

Country
Italy
Department
Nuclear Medicine

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
3
Sites with multiple studies

Has run more than one trial at 3 of 33 partner sites.

Specializations

Advanced Tumor Diagnostics and Treatment

This investigator specializes in the study of metastatic FAP-positive solid tumors and their innovative therapeutic approaches. Their research extends to evaluating novel treatment combinations for advanced cancer cases.

  • FAP-positive tumor targeting
  • Metastatic cancer treatment
  • Combination therapy assessment

Their work involves exploring radioligand-based treatments for advanced solid tumors.

Molecular Imaging and Diagnostics

The investigator focuses on developing and evaluating CXCR4-targeted radiopharmaceuticals for advanced solid tumors. Their research encompasses various cancer types including breast, lung, colon, ovarian, and pancreatic cancers.

  • CXCR4 expression analysis
  • Advanced imaging techniques
  • Pharmacokinetic studies

Their expertise includes immunohistochemistry-based tumor characterization and molecular targeting approaches.

Therapeutic Innovation

This researcher specializes in radiopharmaceutical applications in oncology, with particular emphasis on targeted therapy approaches. Their work involves evaluating novel diagnostic and therapeutic agents for cancer treatment.

  • Targeted cancer therapy
  • Radiopharmaceutical development
  • Advanced tumor treatment strategies

The investigator's focus includes developing personalized approaches for patients with advanced solid tumors.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.